Treponema pallidum macrolide resistance in BC [1]

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 3, 2006, Pages 349-

  Morshed, Muhammad G ^a   Jones, Hugh D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; DOXYCYCLINE; MACROLIDE; TRANSFER RNA;

ANTIBIOTIC RESISTANCE; CANADA; GENE AMPLIFICATION; GENE MUTATION; HETEROSEXUALITY; HUMAN; LETTER; POLYMERASE CHAIN REACTION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREPONEMA PALLIDUM;

EID: 32544446317     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1050256     Document Type: Letter

References (5)

1. Hsi L, Rodes B, Chen CY, et al. New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase 1 gene. J Clin Microbiol 2001;39:1941-6.
2. Lukehart SA, Godornes C, Molini MS, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004;351: 154-8.
3. Health Canada. Canadian STD Guidelines. 1998.
4. US Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002;51(RR-6):1-78.
5. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005;353:1236-44.